Supplementary Table S4 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Andrés Elía (15055031) (author)
Diğer Yazarlar:	Leo Saldain (15055034) (author), Silvia I. Vanzulli (15055037) (author), Luisa A. Helguero (15055040) (author), Caroline A. Lamb (14947288) (author), Victoria Fabris (15055043) (author), Gabriela Pataccini (15055046) (author), Paula Martínez-Vazquez (15055049) (author), Javier Burruchaga (15055052) (author), Ines Caillet-Bois (15055055) (author), Eunice Spengler (15055058) (author), Gabriela Acosta Haab (15055061) (author), Marcos Liguori (15055064) (author), Alejandra Castets (15055067) (author), Silvia Lovisi (15055070) (author), María F. Abascal (15055073) (author), Virginia Novaro (15055076) (author), Jana Sánchez (15055079) (author), Javier Muñoz (15055082) (author), José M. Belizán (15055085) (author), Martín C. Abba (14947131) (author), Hugo Gass (15055088) (author), Paola Rojas (10737201) (author), Claudia Lanari (14947294) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Tumor Biology Clinical Research and Trials Breast Cancer Clinical Trial Results Phase II clinical trials Endocrinology Hormone signaling and inhibitors
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller